AroCell AB Financials
| AROC Stock | SEK 0.40 0.03 6.98% |
AroCell |
Understanding current and past AroCell AB Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of AroCell AB's financial statements are interrelated, with each one affecting the others. For example, an increase in AroCell AB's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in AroCell AB's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of AroCell AB. Check AroCell AB's Beneish M Score to see the likelihood of AroCell AB's management manipulating its earnings.
AroCell AB Stock Summary
AroCell AB competes with Smart Eye, Genovis AB, Kancera AB, and Zignsec AB. AroCell AB , a vitro diagnostics company, focuses on the monitoring of hematological malignancies, breast cancer, and other solid tumors. AroCell AB was founded in 2003 and is based in Uppsala, Sweden. AroCell AB is traded on Stockholm Stock Exchange in Sweden.| Foreign Associate | USA |
| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0003883990 |
| Business Address | Uppsala Business Park, |
| Sector | Life Sciences Tools & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.arocell.com |
| Phone | 46 18 50 30 20 |
| Currency | SEK - Swedish Kronor |
You should never invest in AroCell AB without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of AroCell Stock, because this is throwing your money away. Analyzing the key information contained in AroCell AB's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
AroCell AB Key Financial Ratios
AroCell AB's financial ratios allow both analysts and investors to convert raw data from AroCell AB's financial statements into concise, actionable information that can be used to evaluate the performance of AroCell AB over time and compare it to other companies across industries.AroCell Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AroCell AB's current stock value. Our valuation model uses many indicators to compare AroCell AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AroCell AB competition to find correlations between indicators driving AroCell AB's intrinsic value. More Info.AroCell AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AroCell AB's earnings, one of the primary drivers of an investment's value.AroCell AB Systematic Risk
AroCell AB's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. AroCell AB volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on AroCell AB correlated with the market. If Beta is less than 0 AroCell AB generally moves in the opposite direction as compared to the market. If AroCell AB Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one AroCell AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of AroCell AB is generally in the same direction as the market. If Beta > 1 AroCell AB moves generally in the same direction as, but more than the movement of the benchmark.
AroCell AB November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of AroCell AB help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of AroCell AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of AroCell AB based on widely used predictive technical indicators. In general, we focus on analyzing AroCell Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AroCell AB's daily price indicators and compare them against related drivers.
| Information Ratio | (0.23) | |||
| Maximum Drawdown | 18.16 | |||
| Value At Risk | (6.35) | |||
| Potential Upside | 4.65 |
Additional Tools for AroCell Stock Analysis
When running AroCell AB's price analysis, check to measure AroCell AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AroCell AB is operating at the current time. Most of AroCell AB's value examination focuses on studying past and present price action to predict the probability of AroCell AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AroCell AB's price. Additionally, you may evaluate how the addition of AroCell AB to your portfolios can decrease your overall portfolio volatility.